today announced preclinical data presented at the American Association of Cancer Research Annual Meeting 2021 demonstrating its alpha/beta selective IL-2 partial agonist, STK-012, induced potent ...

Labetalol combines both selective, competitive alpha 1-adrenergic blocking and nonselective, competitive beta-adrenergic blocking activity in a single substance. Beta 2-agonist activity has been ...

Teneobio’s Clinical Candidate, TNB-409, is a Selective IL-2 Receptor Bispecific Agonist for the Treatment of Solid Tumors TeneoBio, Inc Wed, May 19, 2021, 8:00 AM 2 min read ...

Dublin, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The "Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Although beta-2 agonists have been associated with a reduced risk of Parkinson's disease in some previous epidemiological studies, this association was not found in a recent register-based study ...

Although beta-2 agonists have been associated with a reduced risk of Parkinson’s disease in some previous epidemiological studies, this association was not found in a recent register-based study ...

an investigational oral selective orexin 2 receptor agonist. Results from a phase 1b trial demonstrate promise for a novel treatment developed to address the needs of patients with narcolepsy type ...

an oral orexin receptor 2–selective agonist, in patients with narcolepsy type 1. Patients with confirmed narcolepsy type 1 according to clinical criteria were randomly assigned to receive twice ...

Kuopio: Bronchodilators known as beta-2 agonists are extensively used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been linked to a ...

Narcolepsy type 1 is a disorder of hypersomnolence caused by a loss of orexin neurons, which results in low orexin levels in the brain. In this phase 2, randomized, placebo-controlled trial ...